Calabrese, Sarah K. http://orcid.org/0000-0003-2640-0208
Kalwicz, David A.
Modrakovic, Djordje
Earnshaw, Valerie A.
Edelman, E. Jennifer
Bunting, Samuel R.
del Río-González, Ana María
Magnus, Manya
Mayer, Kenneth H.
Hansen, Nathan B.
Kershaw, Trace S.
Rosenberger, Joshua G.
Krakower, Douglas S.
Dovidio, John F.
Funding for this research was provided by:
National Institute of Mental Health (K01-MH103080, P30-MH062294)
National Institutes of Health (P30-AI117970, P30-AI060354)
Article History
Accepted: 8 October 2021
First Online: 9 November 2021
Declarations
:
: SKC, KHM, and DSK have received compensation for their efforts in developing and/or delivering medical education related to PrEP. SKC received partial financial support from Gilead Sciences to attend a research conference. KHM has conducted research with unrestricted project support from Gilead Sciences, Merck, and ViiV Healthcare. DSK has been a consultant to Fenway Health for research studies funded by Gilead Sciences and has a pending grant with unrestricted project support from Merck. The authors have no other relevant financial or non-fianical interests to disclose.
: All study procedures were approved by the Yale University Human Subjects Committee (IRB #HSC-1308012487) and the George Washington University Office of Human Research (IRB #061636) prior to implementation. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Online informed consent to participate was obtained from all study participants.
: Participants were informed of the authors’ intention to publish the results from the study as part of the online consent process.